-

IVI RMA North America 2025 Innovation Summit to Shape the Future of Fertility Care

September Virtual Event will Connect Fertility Experts with Innovative Technologies

BASKING RIDGE, N.J.--(BUSINESS WIRE)--IVI RMA North America, a world-class leader in reproductive medicine and fertility care, is proud to announce its 2025 Innovation Summit—an immersive virtual event designed to foster strategic partnerships and spotlight emerging technologies that will shape the future of reproductive healthcare.

Taking place on September 10 and 11, 2025, the IVI RMA Innovation Summit is a unique opportunity for selected companies and creators to present directly to IVI RMA’s executive leadership and key stakeholders from clinical, lab, and administrative teams. Each organization will receive a dedicated 30-minute presentation slot followed by a live 15-minute question-and-answer session—designed to foster real-time dialogue and meaningful connections.

IVI RMA North America invites forward-thinking startups, research teams, technology leaders, and existing collaborators to be part of this exciting initiative. Whether focused on enhancing patient experience, streamlining clinical operations, or improving fertility treatment outcomes, this event provides a valuable opportunity to contribute to the next chapter of innovation in reproductive medicine.

“IVI RMA North America is committed to pushing the boundaries of what’s possible, and this event demonstrated that commitment, serving not only as a platform for introducing groundbreaking solutions but also as a space to celebrate what IVI RMA has accomplished in partnership with other industry pioneers,” said Lynn Mason, CEO of IVI RMA North America. “The Innovation Summit offers our partners the opportunity to highlight new initiatives, while welcoming new prospective collaborators whose missions align with IVI RMA’s patient-centered, science-driven approach to care.”

As part of IVI RMA Global, the largest assisted reproduction group in the world, IVI RMA North America is backed by more than 4,400 professionals across 190+ locations in 14 countries. To learn more and apply to present at the 2025 IVI RMA Innovation Summit, please visit: rmanetwork.com/innovation-partners.

About IVI RMA North America

IVI RMA North America, comprising Reproductive Medicine Associates, Boston IVF, and Toronto-based TRIO, spans 22 IVF laboratories and has helped women achieve pregnancies which have led to the birth of over 220,000 babies to date. Pioneers in innovative care, including PGT-A, single embryo transfer, fertility preservation, LGBTQ+ care, and more, the network has published over 1,000 papers which have pushed the fertility industry forward. Part of IVI RMA Global, one of the world's leading Reproductive Medicine groups committed to providing evidence-based fertility solutions with the greatest chance of success in the shortest time necessary to patients seeking treatment anywhere in the world. IVI RMA Global employs more than 4,500 people across 200+ locations in 15 countries. Learn more at rmanetwork.com and ivirma.com.

Contacts

IVI RMA North America Contact
Andy Swan, Vice President, Strategic Partnerships
aswan@ivirma.com

IVI RMA North America


Release Versions

Contacts

IVI RMA North America Contact
Andy Swan, Vice President, Strategic Partnerships
aswan@ivirma.com

More News From IVI RMA North America

Boston IVF Partners with Gaia and PatientFi to Make Fertility Treatment More Accessible

BOSTON--(BUSINESS WIRE)--Boston IVF, one of the nation’s leading reproductive service providers and a pioneer in IVF research, today announced new partnerships with Gaia, the first provider of value-based family building, and PatientFi, a modern, patient-friendly financing platform offering zero-interest plan options*, flexible monthly terms up to 84 months**, and financing that covers the entire fertility journey from treatments, and medications to labs, testing, and out-of-pocket expenses. Th...

IVI RMA North America Enters New York City Market through Partnership with Island Reproductive Services

BASKING RIDGE, N.J.--(BUSINESS WIRE)--IVI RMA North America, a leader in fertility care and assisted reproduction, today announced it has finalized a new partnership with Island Reproductive Services (“IRS” or “the Company”), the only reproductive medicine provider on Staten Island to have a fertility lab and offer comprehensive fertility treatment to its patients. The company’s partners, Dr. Eric Knochenhauer and Dr. Michael Traub, will retain an equity stake in the business and continue servi...

The 2025 World Fertility Awards Names First Legacy Award After IVI RMA Global Founder and Chairman, Prof. Antonio Pellicer

MADRID--(BUSINESS WIRE)--The inaugural World Fertility Awards (WFAs), presented by global media platform Pregnantish, has named its 2025 Legacy Award after Professor Antonio Pellicer, Co-Founder and Executive Chair of the Board of Directors for IVI RMA Global. Prof. Pellicer is a renowned IVF pioneer and one of the most influential figures in reproductive medicine. Recognizing his impact on the field, the eponymous 2025 Prof. Antonio Pellicer Legacy Award will be given to an individual whose sc...
Back to Newsroom